Biotech stocks and the related exchange traded fund are in the midst of a lengthy run of disappointing investors. With the NASDAQ Biotechnology Index lower on a year-to-date basis, some market participants might be apt to continue eschewing this segment. Some experts believe that’s not the approach to take. Rather, they see opportunity forming in [...] The post Biotech Rebound Could Boost This ETF appeared first on ETF Trends .